Design Changes After Clearance: When a New 510(k) Is Required

This course strengthens the ability to evaluate post-clearance device changes consistently, determine when existing clearance remains supportable, and document the regulatory rationale behind decisions to submit or not submit a new 510(k).

Changes to a 510(k)-cleared medical device can arise from design improvements, component substitutions, labeling revisions, manufacturing changes, software updates, risk controls, or responses to field experience. Each change requires an assessment of whether it could significantly affect the device’s safety or effectiveness, or whether it represents a major change or modification in intended use. The decision determines whether the change can proceed under the existing clearance or requires submission and clearance of a new 510(k).

This course focuses on the practical evaluation of post-clearance device changes using FDA’s risk-based approach to 510(k) change assessment. It addresses how intended use, labeling, technology, performance, materials, manufacturing, and software-related changes influence the submission decision; how multiple related changes should be considered together; and how risk analysis and supporting testing inform the conclusion. Particular attention is given to documenting decisions when a new 510(k) is determined not to be required.